Revati Shreeniwas

Revati Shreeniwas

Technik-/Wissenschafts-/F&E-Leiter bei ASPEN NEUROSCIENCE, INC.
65 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Revati Shreeniwas, MD, is a Chief Medical Officer at Aspen Neuroscience, Inc., a President at Revati, Inc. and a Member at Continuing Medical Education, Inc. Dr. Shreeniwas was previously employed as a Chief Medical Officer by Bright Minds Biosciences, Inc., a Vice President-Clinical Development by Soleno Therapeutics, Inc., a Chief Medical Officer by NeurAxon Pharma, Inc., a Vice President-Clinical Research & Development by Alvine Pharmaceuticals, Inc., a Principal by CV Therapeutics, Inc., a Principal by Scios, Inc., a Professor by Stanford University, and a Principal by The Trustees of Columbia University in The City of New York.

Aktive Positionen von Revati Shreeniwas

UnternehmenPositionBeginn
ASPEN NEUROSCIENCE, INC. Technik-/Wissenschafts-/F&E-Leiter 01.12.2025
Corporate Officer/Principal -
Revati, Inc.
Präsident 01.01.2004

Ehemalige bekannte Positionen von Revati Shreeniwas

UnternehmenPositionEnde
BRIGHT MINDS BIOSCIENCES INC. Technik-/Wissenschafts-/F&E-Leiter 01.12.2022
SOLENO THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter 01.06.2020
Technik-/Wissenschafts-/F&E-Leiter 01.01.2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Revati Shreeniwas im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

22

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Revati Shreeniwas